IMFINZI
Drug timelines are a Plus or Pro feature.
106 regulatory and trial events tracked for IMFINZI, covering 2017-05-01 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors [Phase 2]